Quick Menu

Upcoming Journals

Silvia Alvarez

 

Dr. Silvia Alvarez

 

I am currently working as Assistant Professor at the Catalysis and Separation Processes Group, Chemical Engineering Department of Complutense University in Madrid (Spain).My research interests are mainly focused on wastewater treatment of pharmaceutical compounds by adsorption, advanced oxidation processes and combined processes of catalytic wet air oxidation and aerobic biological waste water technologies. During my Doctoral Thesis, entitled “Removal of emerging contaminants from waste water by fixed-bed adsorption” I worked about the adsorption removal of emerging micro-pollutants from aqueous phase by adsorption on activated carbons. Specifically I have been working in the removal of emerging contaminants such as: stimulants (caffeine), non-steroidal anti-inflammatory drugs (diclofenac, ibuprofen, naproxen), beta-blockers (atenolol), psychiatric drugs (carbamazepine), antibiotics (flumequine, ciprofloxacin, tetracycline, sulfamethoxazole, metronizadole) and pesticides (isoproturon, diuron) from water by adsorption and mathematical modelling onto carbonaceous adsorbents (activated carbon, carbon nanofibers and nanotubes, carbon cloths, lignocellulosic-based activated carbons, etc.). Therefore, I have broad experience on solids characterization technologies (N2 physisorption, scanning electron microscopy, thermal programmed decomposition, Fourier transform infrared spectra, zero point charge and iso-electric point evaluation). Also, I have studied different synthesis conditions of activated carbons (chemical and physical activation of lignocellulosic precursors, sol-gel synthesis, carbide-derived structures, etc.) In addition, I have worked on the removal of emerging micro-pollutants through advanced oxidation process (catalytic wet peroxide oxidation, catalytic wet air oxidation and the combination with aerobic biological treatments).

Search this site

Advanced Search

Announcement & News

Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and its editors

We are happy to inform that Nature (Impact Factor: 41.6) confirmed high standard of SDI journal and ...

ISI Thomson Reuters selected British Journal of Pharmaceutical Research for Emerging Sources Citation Index

We are delighted to inform that ISI Thomson Reuters selected British Journal of Pharmaceutical Resea...

SCOPUS selected Annual Research & Review in Biology (ARRB)

We are delighted to inform that famous indexing organization SCOPUS (from Elsevier) selected  A...

Index Copernicus Evaluation Result Released

We are delighted to inform that Index Copernicus (a leading indexing organization from Pol...

Journal Repository (JR): Permanent Digital Archiving of SDI journals

SDI is happy to announce that all our journals are now permanently archived in Journal Repository (J...

SDI journal got 35th ranking in Publons

We are delighted to announce (as of 04/01/2016) that British Journal of Medicine and Medical Re...

Growth of SDI and world publication market

As of 2014, total 25,064 journals are competing in World market of journal publication. In 2011, tot...

Science (IF: 31) report confirmed the high standard of SDI journal

As per a recent report (Link) of Science journal (present Impact factor 31), one of our journal (Bri...

SDI introduced Post-publication peer review by its comment section

SDI journals encourage Post-publication peer review by its comment section   Policy details a...

SDI promotes transparent Advanced OPEN peer review

We have migrated to transparent and toughest ‘Advanced OPEN peer review’ system (...



SCIENCEDOMAIN Awards

  • No Awards listed.

Browser Compatibility : Mozila firefox, Google Crome and IE 7 & above. Creative Commons License Terms & Condition   |   Privacy Policy   |   Join Us   |   Help   |   Contact Us
© Copyright 2010-2018, SCIENCEDOMAIN international. All rights reserved.